226 filings
Page 6 of 12
4
Andrew Bellinger
15 Jul 22
Verve Therapeutics / Andrew Bellinger ownership change
5:00pm
4
VERV
Verve Therapeutics Inc
14 Jul 22
Change in insider ownership
5:24pm
EFFECT
VERV
Verve Therapeutics Inc
13 Jul 22
Notice of effectiveness
12:15am
8-K
VERV
Verve Therapeutics Inc
12 Jul 22
Other Events
7:00am
8-K
VERV
Verve Therapeutics Inc
7 Jul 22
Entry into a Material Definitive Agreement
7:06am
4
VERV
Verve Therapeutics Inc
6 Jul 22
Change in insider ownership
12:56pm
S-3
VERV
Verve Therapeutics Inc
1 Jul 22
Shelf registration
4:36pm
4
VERV
Verve Therapeutics Inc
1 Jul 22
Change in insider ownership
2:54pm
4
Krishna Yeshwant
13 Jun 22
Verve Therapeutics / Krishna Yeshwant ownership change
5:01pm
4
Alexander Cumbo
13 Jun 22
Verve Therapeutics / Alexander Cumbo ownership change
5:00pm
4
Adelman Burt A
13 Jun 22
Verve Therapeutics / BURT A ADELMAN ownership change
5:00pm
4
VERV
Verve Therapeutics Inc
13 Jun 22
Verve Therapeutics / Sheila Mikhail ownership change
5:00pm
4
VERV
Verve Therapeutics Inc
13 Jun 22
Verve Therapeutics / Michael F MacLean ownership change
5:00pm
4
John M. Evans
13 Jun 22
Verve Therapeutics / John M. Evans ownership change
5:00pm
3
VERV
Verve Therapeutics Inc
13 Jun 22
Verve Therapeutics / Alexander Cumbo ownership change
4:39pm
8-K
VERV
Verve Therapeutics Inc
13 Jun 22
Departure of Directors or Certain Officers
4:34pm
4
Adelman Burt A
13 May 22
Verve Therapeutics / BURT A ADELMAN ownership change
4:37pm
10-Q
2022 Q1
VERV
Verve Therapeutics Inc
Quarterly report
10 May 22
7:01am
8-K
VERV
Verve Therapeutics Inc
10 May 22
Verve on Track to Begin Dosing HeFH Patients in New Zealand in Mid-2022 in a Phase 1 Clinical Trial with Initial Clinical Data Expected in 2023
6:48am
DEFA14A
VERV
Verve Therapeutics Inc
29 Apr 22
Additional proxy soliciting materials
7:22am